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Abstract. In this study we analyze MR-negative ma­
lignant lesions of the breast. A total of 204 patients 
with palpable and/or mammographie lesions were 
studied. The MR technique consisted of the turbo 
FLASH and MP-RAGE subtraction techniques. All 
patients underwent surgical biopsy and/or mastecto­
my and all specimens were examined by the correla­
tive radiologic-histologic mapping technique, A total 
of 208 lesions were evaluated; 145 turned out to be 
malignant and 63 proved to be benign. Six malignant 
lesions were misinterpreted as benign on MR imag­
ing; thus, suspicious contrast enhancement was pre­
sent in 96 % of the lesions detected by mammogra­
phy, US, or clinical examination. Especially 4 of the 
17 ductal carcinoma in situ (DCIS) lesions were mis­
interpreted (23.5 %). Despite optimal technique, 6 
malignant lesions were not identified by MR imaging. 
The highest prevalence of these MR occult lesions 
was in the group of DCIS. Although MR imaging 
has an important role in the evaluation of breast le­
sions and, primarily, in ruling out malignancy, one 
should be aware of the fact that false-negative MR 
findings do occur.
Key words: Breast neoplasms -  MR -  Contrast en­
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Introduction
Mammography has been considered recently the most 
effective modality for the detection of breast cancer. Its 
sensitivity is close to 90 %  [1]. However, with the use of 
an intravenous gadolinium-containing contrast medium, 
the sensitivity of MR imaging is superior to mammogra­
phy [2]. Various authors claim that absence of contrast 
enhancement practically excludes malignancy [3,4].
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Although the sensitivity of MR imaging is high, nor­
mal glandular tissue may also enhance as well as various 
benign lesions resulting in a specificity of 42 % as re­
ported by Heywang et al. [6], and of 61 % as reported 
by Harms and Flamig [4]. Only Kaiser claims a very 
high specificity of 96.9 % [3].
Data pertinent to false-negative results are relatively 
few [7—9]. In the present study we discuss our 2.5-year 
experience with MR-negative malignant tumors.
Materials and methods
Histologic results and preoperative imaging findings 
(mammography, MR imaging) in 204 women subjected 
to mastectomy or lumpectomy for a malignant or benign 
lesion of the breast were analyzed. The mean age of the 
patients was 52,5 years (range 19-81 years). In 4 patients 
bilateral lesions were present; thus, a total number of 
208 lesions were available for analysis.
For the mammographie examination a CGR 600T 
unit (GE Medical Systems, Milwaukee, Wis.) was used. 
In addition to the standard oblique and craniocaudal 
projections, magnification views in both projections 
were obtained in most cases.
The MR imaging was performed on a Magnetom 63/ 
84 SP4000 (Siemens, Erlangen, Germany) at a field 
strength of 1.5 T. Gadopentetate dimeglumine (Magne- 
vist, Schering, Berlin, Germany) was used as contrast 
medium. A  detailed description of the examination 
technique has been presented elsewhere [10]. Briefly, it 
consists of a 3D MP-RAGE sequence or 3D FLASH se­
quence (slice thickness 1.4 mm, 128 slices, 192 x 256 ma­
trix, 300-mm field of view) before and after intravenous 
injection of a gadolinium-containing contrast medium 
and a turbo FLASH sequence (slice thickness 10 mm, 
63 sequential breast images, 128 x256 matrix, 350-mm 
field of view) during the injection of the contrast medi­
um. Informed consent was obtained in all patients.
A  certain combination of features of both the turbo 
FLASH and M P-RAGE/FLASH sequence were used
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for the differentiation of benign and malignant lesions. 
For the turbo FLASH sequence our main criterion for 
the diagnosis of a malignant lesion is enhancement with­
in 11.5 s after aortic enhancement. In addition, centripe­
tal enhancement was regarded as a sign of malignancy. 
Conversely, late enhancement ( > 11.5 s) anjd centrifugal 
enhancement were regarded as signs of benignancy. On 
the subtracted MP-RAGE/FLASH sequence images 
with focal enhancement, and especially with irregular 
borders, were considered to be suspicious for malignan­
cy. Field enhancement, either diffuse or patchy, was con­
sidered equivocal, as this pattern of enhancement may 
be seen in both benign and malignant lesions [2 ].
Surgical biopsy and mastectomy specimens were ex­
amined pathologically by using a correlative radiologic- 
histologic mapping technique, described in detail else­
where [11].
Results
Of a total of 208 lesions, 63 lesions were benign and 
145 were malignant on histology. In this series suspi­
cious contrast enhancement was present in 96% of 
the lesions detected by mammography, US, or clinical 
examination.
Six malignant lesions were interpreted as benign on 
MR imaging (Table 1). In these cases no or late en­
hancement on the turbo FLASH, and either no en­
hancement at all or enhancement equal to that of the 
contralateral breast (symmetric enhancement) on the 
MP-RAGE sequence, was noted. The histologic diag­
noses are presented in Table 2. Four cases of ductal car­
cinoma in situ (DCIS) from a total of 17 were occult on 
MR imaging. In addition, two invasive cancers were 
not identified. In one case, biopsy findings showed a 
mucinous carcinoma of 2 mm with an associated DCIS 
of 10 mm. The other case was an invasive lobular carci­
noma (ILC) of 40 mm.
Discussion
The role of MR imaging in addition to mammography is 
based on its high sensitivity in tumor detection due to 
the consistent contrast enhancement of breast cancer. 
Harms et al. [12] claimed that all types of breast cancer 
enhance, that enhancement of the tumor is always 
stronger compared with normal breast tissue, and that 
lack of enhancement indicates a benign lesion or normal 
tissue. Even pre-invasive lesions, such as DCIS and lob­
ular carcinoma in situ, showed stronger enhancement 
than normal glandular tissues in their series [12]. A c­
cording to Heywang-Köbrunner the absence of contrast 
enhancement excludes malignancy with a high probabil­
ity, but due to possible errors MR imaging is not used for 
differentiation of microcalcifications [13]. Kaiser stated 
that lack of significant enhancement ( > 500 N U ) im­
plies the presence of normal breast tissue [3].
Malignant tumors of the breast often show an in­
creased capillary network with increased permeabili-
Table 1. Clinical and radiologic data in six MR-negative tumors. 
DCIS ductal carcinoma in situ
Tumor Age Palpable Mammo- US Pathology 
no. (years) graphy
1 52 — -  2.5-mm non-comedo
DCIS
2 51 — + -  100-mm non-comedo
DCIS
3 65 — + -  10-mm non-comedo
DCIS
4 53 — + -  50-mm comedo DCIS
5 54 + + -  40-mm invasive 
lobular carcinoma




NOTE: + Positive for malignancy; -  negative for malignancy; 0 not 
performed
Table 2. Specification of MR-negative tumors according to histol­
ogy. IDC invasive duct carcinoma; DCIS ductal carcinoma in situ; 
ILC invasive lobular carcinoma; TUB tubular carcinoma
Histology NR False-negative
IDC 91 1 (1%)
DCIS 17 4 (23,5 %)
ILC 30 1 (3%)
M ED 6 0
TUB 2 0
ty, factors which contribute to the earlier and 
stronger contrast enhancement in breast malignan­
cies [14].
In our series, of 145 histologically confirmed malig­
nant tumors, 6 (4%) could not be recognized on gado­
linium-enhanced MR imaging, because no abnormal en­
hancement was seen (Table 1). Four lesions proved to 
be a DCIS of which 3 were of the non-comedo (well-dif- 
ferentiated) type (for histologic subclassification of 
DCIS see [15]) with a diameter of 2.5,10, and 90 mm, re­
spectively, suggesting that tumor size alone is not re­
sponsible of these false-negative results. These three 
cases did not show increased enhancement on either 
the turbo FLASH or MP-RAGE, or the FLASH se­
quence, compared with normal tissue. However, anoth­
er five cases of non-comedo DCIS did show enhance­
ment within the threshold of 11.5 s on the turbo FLASH 
sequence with sizes of 10-70 mm in greatest diameter. 
Overall, only 62.5 % of the non-comedo DCIS were rec­
ognized in this series.
Another case of MR occult DCIS was histologically 
a comedo (poorly differentiated) type of 50 mm. In 
this case the region of interest was very likely out of 
the chosen level of the turbo FLASH sequence. On 
the MP-RAGE sequence the lesion enhanced slightly 
more than the surrounding glandular tissue, but not en­
ough to be considered as suspect for malignancy. Seven 
other patients with a poorly or intermediately differen­
tiated DCIS did enhance significantly on both the tur-
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F ig .la ,b .  A  53-year-old patient
underwent a mastectomy of the left 
breast, 4 years before* for an inva­
sive lobular carcinoma. On physical 
examination the right breast is 
firmer now. a Mammography 
showed a slightly distorted area in 
the retromamillar region (arrows) 
and US was normal, b An MR 
imaging examination showed en­
hancement on both the turbo 
FLASH and M P-RAGE sequence, 
but was interpreted as normal. His­
tology revealed a 40-mm invasive 
lobular carcinoma, non-tumor 
forming, with diffuse spread of tu­
mor cells
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bo FLASH and the 3D MP-RAGE or FLASH se­
quence.
Guidi et al. suggest that different subtypes of DCIS 
show different patterns of stromal microvessels, and 
that especially the comedo DCIS has a diffuse increase 
in such microvessels [16]. Perhaps this is one of the rea­
sons that the comedo DCIS generally shows more en­
hancement than the non-comedo type.
Harms et al. [12] reported on 57 patients with 42 ma­
lignancies, including all cases of DCIS, all showing sig­
nificantly more enhancement than the normal tissue; 
however, the subtype of DCIS was not mentioned.
Gilles et al. also reported on a series of 26 cases of 
DCIS which all show early enhancement [7]. On the 
other hand, Greenstein Orel et al [8] stated that small 
foci of DCIS are not visible on MR imaging. Heywang- 
Köbrunner [2] agrees with Allgayer et al. [17] in that 
MR imaging is not good in differentiating lesions with 
mammographie microcalcifications because both DCIS 
and proliferative dysplasia can be associated with mic­
rocalcifications and may both show abnormal enhance­
ment.
Fig.2 a, b. A  52-year-old woman with a non-palpable, but mammo- 
graphically suspicious, lesion in the left breast detected during 
mass screening, a Mammography showed coarse granular micro­
calcifications over an area of 10 mm (arrow), b Subtracted MP- 
R A G E  showed an enhancing lesion on the corresponding site, but 
on the turbo FLASH sequence enhancement was noted only after 
18.4 s. Histology revealed a 2-mm mucinous carcinoma with an 
area of non-comedo ductal carcinoma in situ of 10 mm around the 
invasive part
an invasive lobular carcinoma (ILC), the start of en­
hancement on the turbo FLASH sequence was not with­
in the limit of 11.5 s, our threshold for malignancy 
(Fig. 1) [10]. On the 3D M P-RAGE sequence the degree 
of enhancement was regarded as normal. However, the 
contralateral breast had already been amputated and 
thus could not serve as reference. Histology revealed 
an ILC 40 mm in diameter. This tumor showed a pecu­
liar histologic growth pattern in which tumor cells were 
diffusely spread through thin fibrous threads between 
normal fatty areas. Wilhelm et al. [9] also reported on a 
false-negative case of ILC of 20 mm with diffuse growth 
pattern. Gilles et al. [7] in a series of 64 breast malignan­
cies described 2 cases of an ILC in which no early con­
trast enhancement was seen.
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Finally, 1 case of invasive duct carcinoma (IDC) 
turned out to be false-negative (Fig. 2). In this case in a 
small area of 10 mm coarse granular microcalcifications 
were seen on the mammogram. Ultrasound was not per­
formed. The unenhanced 3D MP-RAGE images 
showed a low-signal-intensity area corresponding to 
the area of microcalcifications on the mammography. 
On the turbo FLASH sequence an area of vague en­
hancement starting 18.4 s after the aortic enhancement 
was seen. Thus, the threshold of 11.5 s was exceeded. 
On the enhanced MP-RAGE sequence the other parts 
of both breasts showed signal intensity similar to that 
of the suspicious area. Histology revealed a 2-mm muc­
inous carcinoma associated with an area of non-comedo 
DCIS of 10 mm. This patient had voluminous breasts 
and the lesion was situated adjacent to the pectoral mus­
cle. As the sensitivity of the coil decreases with increas­
ing distance between the lesion and the coil, the sensitiv­
ity for this lesion was perhaps not sufficient in this pa­
tient [18].
In conclusion, our retrospective analysis of 145 histo­
logically proven malignant tumors shows that despite 
optimal technique, not all of these tumors were revealed 
with MR imaging: 6 cases (4%) did not fulfill our main 
criterion of early enhancement on the turbo FLASH se­
quence. On the 3D MP-RAGE/FLASH sequence these 
lesions did not show any abnormal enhancement either. 
The highest prevalence of false-negative cases was in the 
group of DCIS: 23.5 % were missed. The non-comedo 
DCIS cases were especially responsible for these diag­
nostic failures. In addition, also a case of ILC was mis­
sed. Although MR imaging plays an important role in 
the detection of breast cancers, primarily in high-risk 
patients, one should be aware of the fact that false-nega­
tive MR findings do occur in a small percentage of cases. 
In all but one of our MR-negative cases was the mam­
mography suspected of showing malignancy. Mammog­
raphy remains the main diagnostic technique for exam­
ination of the breasts. The MR imaging technique is of 
complementary value in better delineation of tumor 
size, in detecting additional malignant lesions, and in 
mammographically difficult, dense breasts [19].
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